Philogen SpA 2024 SR
The report highlights Philogen Group's 2024 sustainability progress, including the submission of a marketing authorization application for Nidlegy™ to the EMA. The company expanded its clinical trials to 130 centers and treated 328 new patients. Environmentally, the Group reduced energy consumption by 12% and increased its photovoltaic capacity to 440 kW. Socially, the workforce grew by 10% to 183 employees, with women representing 61% of the staff. The Group also achieved a significant increase in economic value generated, reaching 80.4 million euros.
Company: Philogen SpA
Sector: Health Care
Country: Italy
Year: 2024
Type: SR
Pages: 92
Philogen SpA
Sustainability Report
The report highlights Philogen Group's 2024 sustainability progress, including the submission of a marketing authorization application for Nidlegy™ to the EMA. The company expanded its clinical trials to 130 centers and treated 328 new patients. Environmentally, the Group reduced energy consumption by 12% and increased its photovoltaic capacity to 440 kW. Socially, the workforce grew by 10% to 183 employees, with women representing 61% of the staff. The Group also achieved a significant increase in economic value generated, reaching 80.4 million euros.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Mar 27, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees